GLP-1R/GIPR/Pan-PPAR quintuple agonist (DZD)

N/A

Report date: 2026/04/10 20:01:49

NME

Base Information

Drug NameGLP-1R/GIPR/Pan-PPAR quintuple agonist (DZD)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon-like peptide 1 receptor agonistsPeroxisome proliferator activated receptor agonists

TargetsGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon-like peptide 1 receptorPeroxisome proliferator activated receptor

Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDeutsches Zentrum für Diabetesforschung

China Registration ClassN/A

Develop Information

Active CompaniesDeutsches Zentrum für Diabetesforschung

Inactive CompaniesN/A

Active IndicationsObesityDiabetes Mellitus, Type 2

Inactive IndicationsN/A

Other Information

ATC CodeN/A